Search Results - "Simona, Carolina"
-
1
A randomised phase II study of osimertinib and bevacizumab versus osimertinib alone as second-line targeted treatment in advanced NSCLC with confirmed EGFR and acquired T790M mutations: the European Thoracic Oncology Platform (ETOP 10-16) BOOSTER trial
Published in Annals of oncology (01-02-2022)“…While osimertinib, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) is the standard treatment in patients with…”
Get full text
Journal Article -
2
Short acting insulin analogues in intensive care unit patients
Published in World journal of diabetes (15-06-2014)“…Blood glucose control in intensive care unit(ICU) patients, addressed to actively maintain blood glucose concentration within defined thresholds, is based on…”
Get full text
Journal Article